SCYNEXIS, Inc. Gain (Loss) on Extinguishment of Debt
SCYNEXIS, Inc. (SCYX) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2023-03-31
- SCYNEXIS, Inc. gain (loss) on extinguishment of debt for the quarter ending 2022-12-31 was $0.00.
- SCYNEXIS, Inc. gain (loss) on extinguishment of debt for the quarter ending 2022-09-30 was $0.00.
- SCYNEXIS, Inc. gain (loss) on extinguishment of debt for the quarter ending 2022-06-30 was $0.00.
- SCYNEXIS, Inc. gain (loss) on extinguishment of debt for the quarter ending 2022-03-31 was $0.00.
- SCYNEXIS, Inc. gain (loss) on extinguishment of debt for fiscal 2022 was $0.00.
- SCYNEXIS, Inc. gain (loss) on extinguishment of debt for fiscal 2021 was -$2.73M.
- SCYNEXIS, Inc. gain (loss) on extinguishment of debt for fiscal 2020 was -$1.77M.
- SCYNEXIS, Inc. gain (loss) on extinguishment of debt for fiscal 2019 was -$1.04M.
| Period end | Gain (Loss) on Extinguishment of Debt 1 month | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 4 quarters · filed 2023-03-31 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $0.00 derived: sum of 4 quarters · filed 2023-03-31 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $0.00 derived: sum of 4 quarters · filed 2023-03-31 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | -$2.73M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | -$2.73M 10-Q · filed 2022-11-09 | -$3.69M derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-15 | -$2.73M 10-Q · filed 2022-08-15 | -$3.69M derived: sum of 3 quarters · filed 2022-08-15 | -$3.69M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | -$2.73M 10-Q · filed 2022-05-12 | -$3.69M derived: sum of 2 quarters · filed 2022-05-12 | -$3.69M derived: sum of 3 quarters · filed 2022-05-12 | -$4.49M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2021-01-31 | $2.70M 10-K · filed 2022-03-29 | ||||
| 2020-12-31 | $1.00M 10-K · filed 2022-03-29 | -$960.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$960.00K derived: sum of 2 quarters · filed 2022-03-29 | -$1.77M derived: sum of 3 quarters · filed 2022-03-29 | -$1.77M 10-K · filed 2022-03-29 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | -$806.00K derived: sum of 2 quarters · filed 2021-11-10 | -$806.00K 10-Q · filed 2021-11-10 | -$806.00K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $800.00K 10-K · filed 2022-03-29 | -$806.00K 10-Q · filed 2021-08-16 | -$806.00K 10-Q · filed 2021-08-16 | -$806.00K derived: sum of 3 quarters · filed 2021-08-16 | -$806.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-17 | $0.00 derived: sum of 2 quarters · filed 2021-05-17 | $0.00 derived: sum of 3 quarters · filed 2021-05-17 | -$231.00K derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $0.00 derived: sum of 2 quarters · filed 2021-03-29 | -$231.00K derived: sum of 3 quarters · filed 2021-03-29 | -$1.04M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-06 | -$231.00K derived: sum of 2 quarters · filed 2020-11-06 | -$1.04M 10-Q · filed 2020-11-06 | -$1.04M derived: sum of 4 quarters · filed 2020-11-06 | |
| 2019-06-30 | -$231.00K 10-Q · filed 2020-08-10 | -$1.04M 10-Q · filed 2020-08-10 | -$1.04M derived: sum of 3 quarters · filed 2020-08-10 | -$1.04M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | -$814.00K 10-Q · filed 2020-05-11 | -$814.00K derived: sum of 2 quarters · filed 2020-05-11 | -$814.00K derived: sum of 3 quarters · filed 2020-05-11 | -$814.00K derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $0.00 derived: sum of 2 quarters · filed 2020-03-11 | $0.00 derived: sum of 3 quarters · filed 2020-03-11 | $0.00 10-K · filed 2020-03-11 | |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-07 | $0.00 10-Q · filed 2019-08-07 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-08 | ||||
| 2016-12-31 | $0.00 10-K · filed 2017-03-13 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $0.00 derived: sum of 2 quarters · filed 2017-03-13 | $0.00 derived: sum of 3 quarters · filed 2017-03-13 | $0.00 10-K · filed 2017-03-13 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-13 | $0.00 derived: sum of 2 quarters · filed 2015-11-13 | $0.00 10-Q · filed 2015-11-13 | ||
| 2015-06-30 | $0.00 10-Q · filed 2015-08-19 | $0.00 10-Q · filed 2015-08-19 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $0.00 derived: sum of 2 quarters · filed 2017-03-13 | -$1.39M derived: sum of 3 quarters · filed 2017-03-13 | -$1.39M 10-K · filed 2017-03-13 | |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-13 | -$1.39M derived: sum of 2 quarters · filed 2015-11-13 | -$1.39M 10-Q · filed 2015-11-13 | ||
| 2014-06-30 | -$1.39M 10-Q · filed 2015-08-19 | -$1.39M 10-Q · filed 2015-08-19 | |||
| 2013-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30 | $0.00 derived: sum of 2 quarters · filed 2015-10-30 | $0.00 derived: sum of 3 quarters · filed 2015-10-30 | $0.00 8-K · filed 2015-10-30 | |
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-13 | $0.00 10-Q · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |